| __timestamp | Cytokinetics, Incorporated | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 3788000000 |
| Thursday, January 1, 2015 | 46398000 | 4006000000 |
| Friday, January 1, 2016 | 59897000 | 4261000000 |
| Sunday, January 1, 2017 | 90296000 | 4371000000 |
| Monday, January 1, 2018 | 89135000 | 4853000000 |
| Tuesday, January 1, 2019 | 86125000 | 4675000000 |
| Wednesday, January 1, 2020 | 96951000 | 4572000000 |
| Friday, January 1, 2021 | 159938000 | 6601000000 |
| Saturday, January 1, 2022 | 240813000 | 5657000000 |
| Sunday, January 1, 2023 | 330123000 | 6498000000 |
| Monday, January 1, 2024 | 28675800000 |
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. Over the past decade, Gilead Sciences, Inc. and Cytokinetics, Incorporated have shown distinct financial trajectories. Gilead, a giant in the sector, consistently reported a cost of revenue averaging around $4.9 billion annually, peaking at $6.6 billion in 2021. This reflects its expansive operations and market reach. In contrast, Cytokinetics, a smaller player, saw its cost of revenue grow by over 640% from 2014 to 2023, highlighting its aggressive expansion and investment in research. By 2023, Cytokinetics' cost of revenue reached approximately 5% of Gilead's, a significant leap from just 1% in 2014. This data underscores the dynamic nature of the pharmaceutical landscape, where strategic investments can lead to substantial growth, even for smaller companies.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Gilead Sciences, Inc.
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Intra-Cellular Therapies, Inc.
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Alkermes plc
Cost of Revenue: Key Insights for Gilead Sciences, Inc. and Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Travere Therapeutics, Inc.
Analyzing Cost of Revenue: Viatris Inc. and Cytokinetics, Incorporated
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Cost of Revenue Trends: Halozyme Therapeutics, Inc. vs Cytokinetics, Incorporated
Grifols, S.A. vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Cytokinetics, Incorporated and Amphastar Pharmaceuticals, Inc.'s Expenses
Cytokinetics, Incorporated vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored